Lead Product(s) : Undisclosed
Therapeutic Area : Genetic Disease
Study Phase : Undisclosed
Sponsor : Sanofi
Deal Size : Undisclosed
Deal Type : Collaboration
Details : Sanofi, together with SIRION will develop new and modified AAV capsids that exhibit a safe product profile with improved specificity and higher gene delivery efficiency.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
February 23, 2021
Lead Product(s) : Undisclosed
Therapeutic Area : Genetic Disease
Highest Development Status : Undisclosed
Sponsor : Sanofi
Deal Size : Undisclosed
Deal Type : Collaboration